Price $97.44 |
Market Cap
149.7B
|
Sector Health Care |
Div. Growth
-10.20%
|
|
P/E
17.1
|
P/B
29.64
|
P/S
5.35
|
Dividend %
4.10%
|
|
P/CF
36.1
|
P/FCF
28.5
|
Op. Cash Flow
9.96M
|
FCF
3.3
|
|
Op. Margin
34.00%
|
Net Margin
18.70%
|
ROE
92.70%
|
ROI
25.40%
|
|
ROA
7.80%
|
EPS Growth
-26.10%
|
Current Ratio
1.3
|
Debt/Equity
607.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $7.95 | - | - | 113.3M | Strong Buy |
| Digirad Corporation (DRAD) | $1.50 | - | 14.20% | 31.1M | Strong Buy |
| Tenet Healthcare Corp (THC) | $23.28 | - | - | 2.41B | Strong Buy |
| Depomed Inc (DEPO) | $6.63 | - | - | 415.3M | Strong Buy |
| Nephros, Inc. (NEPH) | $0.56 | - | - | 23.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
